Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1855 1
1871 1
1887 1
1946 2
1947 3
1948 5
1949 4
1950 3
1951 5
1952 8
1953 7
1954 7
1955 8
1956 9
1957 5
1958 5
1959 2
1960 4
1961 10
1962 6
1963 12
1964 26
1965 32
1966 11
1967 11
1968 15
1969 26
1970 15
1971 20
1972 32
1973 32
1974 18
1975 19
1976 13
1977 24
1978 28
1979 34
1980 28
1981 31
1982 36
1983 31
1984 41
1985 37
1986 36
1987 37
1988 49
1989 33
1990 51
1991 31
1992 34
1993 29
1994 33
1995 45
1996 48
1997 38
1998 46
1999 44
2000 47
2001 45
2002 47
2003 49
2004 52
2005 59
2006 49
2007 62
2008 55
2009 44
2010 60
2011 60
2012 62
2013 76
2014 78
2015 81
2016 88
2017 85
2018 81
2019 70
2020 92
2021 52
Text availability
Article attribute
Article type
Publication date

Search Results

2,479 results
Results by year
Filters applied: . Clear all
Page 1
Tumor targeting via EPR: Strategies to enhance patient responses.
Golombek SK, May JN, Theek B, Appold L, Drude N, Kiessling F, Lammers T. Golombek SK, et al. Among authors: may jn. Adv Drug Deliv Rev. 2018 May;130:17-38. doi: 10.1016/j.addr.2018.07.007. Epub 2018 Jul 19. Adv Drug Deliv Rev. 2018. PMID: 30009886 Free PMC article. Review.
Update to Practice Standards for Electrocardiographic Monitoring in Hospital Settings: A Scientific Statement From the American Heart Association.
Sandau KE, Funk M, Auerbach A, Barsness GW, Blum K, Cvach M, Lampert R, May JL, McDaniel GM, Perez MV, Sendelbach S, Sommargren CE, Wang PJ; American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Clinical Cardiology; and Council on Cardiovascular Disease in the Young. Sandau KE, et al. Among authors: may jl. Circulation. 2017 Nov 7;136(19):e273-e344. doi: 10.1161/CIR.0000000000000527. Epub 2017 Oct 3. Circulation. 2017. PMID: 28974521 Review.
Comparative effectiveness of extended-release naltrexone versus buprenorphine-naloxone for opioid relapse prevention (X:BOT): a multicentre, open-label, randomised controlled trial.
Lee JD, Nunes EV Jr, Novo P, Bachrach K, Bailey GL, Bhatt S, Farkas S, Fishman M, Gauthier P, Hodgkins CC, King J, Lindblad R, Liu D, Matthews AG, May J, Peavy KM, Ross S, Salazar D, Schkolnik P, Shmueli-Blumberg D, Stablein D, Subramaniam G, Rotrosen J. Lee JD, et al. Among authors: may j. Lancet. 2018 Jan 27;391(10118):309-318. doi: 10.1016/S0140-6736(17)32812-X. Epub 2017 Nov 14. Lancet. 2018. PMID: 29150198 Free PMC article. Clinical Trial.
IDH3Ī± regulates one-carbon metabolism in glioblastoma.
May JL, Kouri FM, Hurley LA, Liu J, Tommasini-Ghelfi S, Ji Y, Gao P, Calvert AE, Lee A, Chandel NS, Davuluri RV, Horbinski CM, Locasale JW, Stegh AH. May JL, et al. Sci Adv. 2019 Jan 2;5(1):eaat0456. doi: 10.1126/sciadv.aat0456. eCollection 2019 Jan. Sci Adv. 2019. PMID: 30613765 Free PMC article.
2,479 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page